Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 6, 2012, Pages 946-954

  Don, Creighton ^a,b   Gupta, Pritha P ^b   Witzke, Christian ^a   Kesarwani, Manoj ^b   Cubeddu, Roberto J ^a,c   Inglessis, Ignacio ^a   Palacios, Igor F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c Division of Cardiology   (United States)

Author keywords

aortic valve stenosis; hypertrophic obstructive cardiomyopathy; left ventricular hypertrophy; subaortic stenosis

Indexed keywords

HYPERTENSIVE AGENT;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; AGED; AORTA VALVE STENOSIS; ARTERIOVENOUS FISTULA; ARTICLE; BODY SURFACE; CALCIFICATION; CARDIOPULMONARY ARREST; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; ELECTROCARDIOGRAPHY; FALSE ANEURYSM; FEMALE; GENERAL HOSPITAL; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART TAMPONADE; HEART VENTRICLE SIZE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTUBATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE HEMORRHAGE; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK; SMALL HEART LEFT VENTRICLE SIZE; SYSTOLIC BLOOD PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BALLOON VALVULOPLASTY; BODY SURFACE AREA; BOSTON; CALCINOSIS; FEMALE; HEART VENTRICLES; HOSPITALS, GENERAL; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84869497608     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24287     Document Type: Article

References (37)

1. Eltchaninoff H, Cribier A, Tron C, Anselme F, Koning R, Soyer R, Letac B,. Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. Eur Heart J 1995; 16: 1079-1084.
2. Sack S, Kahlert P, Khandanpour S, Naber C, Philipp S, Möhlenkamp S, Sievers B, Kälsch H, Erbel R,. Revival of an old method with new techniques: Balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol 2008; 97: 288-297.
3. McKay RG,. The mansfield scientific aortic valvuloplasty registry: Overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 1991; 17: 485-491.
4. Block P, Palacios I,. Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. Am J Cardiol 1988; 62: 760-763.
5. Agarwal A, Kini AS, Attanti S, Lee PC, Ashtiani R, Steinheimer AM, Moreno PR, Sharma SK,. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005; 95: 43-47.
6. Reeder G, Nishimura R, Holmes DJ,. Patient age and results of balloon aortic valvuloplasty: The mansfield scientific registry experience. The mansfield scientific aortic valvuloplasty registry investigators. J Am Coll Cardiol 1991; 17: 909-913.
7. Kastrup J, Wennevold A, Thuesen L, Nielsen T, Kassis E, Fritz-Hansen P, Thayssen P,. Short- and long-term survival after aortic balloon valvuloplasty for calcified aortic stenosis in 137 elderly patients. Dan Med Bull 1994; 41: 362-365.
8. Hess OM, Schneider J, Turina M, Carroll JD, Rothlin M, Krayenbuehl HP,. Asymmetric septal hypertrophy in patients with aortic stenosis: An adaptive mechanism or a coexistence of hypertrophic cardiomyopathy? J Am Coll Cardiol 1983; 1: 783-789.
9. Panza JA, Maron BJ,. Valvular aortic stenosis and asymmetric septal hypertrophy: Diagnostic considerations and clinical and therapeutic implications. Eur Heart J 1988; 9 (Suppl E): 71-76.
10. Aurigemma G, Battista S, Orsinelli D, Sweeney A, Pape L, Cuenoud H,. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality. Circulation 1992; 86: 926-936.
11. Rodriguez A, Kleiman N, Minor S, Zoghbi W, West M, DeFelice C, Samuels D, Cashion R, Pickett J, Lewis J,. Factors influencing the outcome of balloon aortic valvuloplasty in the elderly. Am Heart J 1990; 120: 373-380.
12. Suh WM, Witzke CF, Palacios IF,. Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 616-620.
13. Letac B, Cribier A, Koning R, Lefebvre E,. Aortic stenosis in elderly patients aged 80 or older. Treatment by percutaneous balloon valvuloplasty in a series of 92 cases. Circulation 1989; 80: 1514-1520
14. Waikar SS, Bonventre JV,. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009; 20: 672-679.
15. Troy BL, Pombo J, Rackley CE,. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 1972; 45: 602-611.
16. Feizi O, Farrer Brown G, Emanuel R,. Familial study of hypertrophic cardiomyopathy and congenital aortic valve disease. Am J Cardiol 1978; 41: 956-964.
17. Brown PS Jr, Roberts CS, McIntosh CL, Roberts WC, Clark RE,. Combined obstructive hypertrophic cardiomyopathy and stenotic congenitally bicuspid aortic valve. Am J Cardiol 1990; 66: 1273-1275.
18. Harrison EE, Sbar SS, Martin H, Pupello DF,. Coexisting right and left hypertrophic subvalvular stenosis and fixed left ventricular outflow obstruction due to aortic valve stenosis. Am J Cardiol 1977; 40: 133-136.
19. Wiseth R, Skjaerpe T, Hatle L,. Rapid systolic intraventricular velocities after valve replacement for aortic stenosis. Am J Cardiol 1993; 71: 944-948.
20. Bartunek J, Sys SU, Rodrigues AC, van Schuerbeeck E, Mortier L, de Bruyne B,. Abnormal systolic intraventricular flow velocities after valve replacement for aortic stenosis. Mechanisms, predictive factors, and prognostic significance. Circulation 1996; 93: 712-719.
21. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH,. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993; 22: 1679-1683.
22. Karam R, Lever HM, Healy BP,. Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol 1989; 13: 580-584.
23. Kunkel B, Schneider M,. Myocardial structure and left ventricular function in hypertrophic and dilative cardiomyopathy and aortic valve disease. Z Kardiol 1987; 76 (Suppl 3): 9-13.
24. Iwakami M, Numano F,. Regional wall motion abnormalities during early diastole in patients with hypertensive left ventricular hypertrophy: A doppler tissue echocardiographic study. J Med Dent Sci 2001; 48: 45-49.
25. Sgreccia A, Morabito G, Gurgo Di Castelmenardo A, Bernardo ML, Petrilli AC, De Leva R, De Marzio P, Nuccio F, Morelli S,. Congestive heart failure in hypertensive patients with normal systolic function and dynamic left ventricular outflow obstruction. Minerva Cardioangiol 2001; 49: 99-106.
26. Don CW, Witzke C, Cubeddu RJ, Herrero-Garibi J, Pomerantsev E, Caldera AE, McCarty D, Inglessis I, Palacios IF,. Comparison of procedural and in-hospital outcomes of percutaneous balloon aortic valvuloplasty in patients >80 years versus patients < or =80 years. Am J Cardiol 2010; 105: 1815-1820.
27. Bernard Y, Etievent J, Mourand J, Anguenot T, Schiele F, Guseibat M, Bassand J,. Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old. J Am Coll Cardiol 1992; 20: 796-801.
28. Kapadia SR, Goel SS, Svensson L, Roselli E, Savage RM, Wallace L, Sola S, Schoenhagen P, Shishehbor MH, Christofferson R, Halley C, Rodriguez LL, Stewart W, Kalahasti V, Tuzcu EM,. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg 2009; 137: 1430-1435.
29. Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF,. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 1994; 23: 1071-1075.
30. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS,. 2008 focused update incorporated into the acc/aha 2006 guidelines for the management of patients with valvular heart disease: A report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 2008; 52: e1-142.
31. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB,. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
32. Witzke C, Don CW, Cubeddu RJ, Herrero-Garibi J, Pomerantsev E, Caldera A, McCarty D, Inglessis I, Palacios IF,. Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: Should we be using it? Catheter Cardiovasc Interv 2010; 75: 444-452.
33. Pedersen W, Klaassen P, Pedersen C, Wilson J, Harris K, Goldenberg I, Poulose A, Mooney M, Henry T, Schwartz R,. Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone. Am J Cardiol 2008; 101: 1309-1314.
34. Cubeddu RJ, Jneid H, Don CW, Witzke CF, Cruz-Gonzalez I, Gupta R, Rengifo-Moreno P, Maree AO, Inglessis I, Palacios IF,. Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: Immediate, short- and long-term outcome at 2 years. Catheter Cardiovasc Interv 2009; 74: 225-231.
35. Hamid T, Eichhofer J, Clarke B, Mahadevan VS,. Aortic balloon valvuloplasty: Is there still a role in high-risk patients in the era of percutaneous aortic valve replacement? J Interv Cardiol 2010; 23: 358-361.
36. Lieberman E, Bashore T, Hermiller J, Wilson J, Pieper K, Keeler G, Pierce C, Kisslo K, Harrison J, Davidson C,. Balloon aortic valvuloplasty in adults: Failure of procedure to improve long-term survival. J Am Coll Cardiol 1995; 26: 1522-1528.
37. Elmariah S, Lubitz SA, Shah AM, Miller MA, Kaplish D, Kothari S, Moreno PR, Kini AS, Sharma SK,. A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: The crrac the av score. Catheter Cardiovasc Interv 2011; 78: 112-118.